NEU neuren pharmaceuticals limited

Ann: Share Purchase Plan Offer Booklet, page-19

  1. 476 Posts.
    lightbulb Created with Sketch. 79
    It's very difficult to think that the FDA and everyone else would risk very young children in a trial if they weren't confident that there was a benefit to be had and that it was safe to do so.

    Does anyone know the number of people who continued into the Lilac trial from Lavender? The best test would be if a large number continued, as it would indicate a benefit.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.20
Change
0.890(6.69%)
Mkt cap ! $1.761B
Open High Low Value Volume
$13.50 $14.26 $12.96 $9.111M 655.8K

Buyers (Bids)

No. Vol. Price($)
1 2000 $14.17
 

Sellers (Offers)

Price($) Vol. No.
$14.23 3278 1
View Market Depth
Last trade - 16.15pm 27/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.